ConductScience.org, home

Paper39495000

Life-threatening antibodies: The discovery of anaphylaxis.

Daëron M and 2 others. Immunol Rev, 2024. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Life-threatening antibodies: The discovery of anaphylaxis. Papers, record 39495000. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39495000

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Life-threatening antibodies: The discovery of anaphylaxis.
PubMed
Journal
Immunol Rev
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review, Historical Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.13, provisional
iCite
Revised in PubMed
2026-08-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Daëron MMarchttps://orcid.org/0000-0002-5651-9851
2Heyman BBirgittahttps://orcid.org/0000-0003-0869-0483
3Moulin AMAnne Mariehttps://orcid.org/0000-0002-1652-3880

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AnaphylaxisMajor topic
Humans
Animals
History, 20th Century
Antibodies
Hypersensitivity

Source PubMed

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116,785,568Fc gamma RIIa, not Fc gamma RIIb, is constitutively and functionally expressed on skin-derived human mast cells.J Immunol2006https://conductscience.org/library/papers/16785568PubMed
211,941,316Pathways of anaphylaxis in the mouse.J Allergy Clin Immunol2002https://conductscience.org/library/papers/11941316PubMed
325,042,981Oral immunotherapy induces IgG antibodies that act through FcγRIIb to suppress IgE-mediated hypersensitivity.J Allergy Clin Immunol2014https://conductscience.org/library/papers/25042981PubMed
44,186,069Behaviour of mouse mast cells during anaphylaxis in vitro.Prog Allergy1969https://conductscience.org/library/papers/4186069PubMed
513,673,141Studies on the mechanism of hypersensitivity phenomena. III. The participation of complement in the formation of anaphylatoxin.J Exp Med1959https://conductscience.org/library/papers/13673141PubMed
633,854,500Innate Immune Memory in Hematopoietic Stem/Progenitor Cells: Myeloid-Biased Differentiation and the Role of Interferon.Front Immunol2021https://conductscience.org/library/papers/33854500PubMed
720,498,670Mast cell-orchestrated immunity to pathogens.Nat Rev Immunol2010https://conductscience.org/library/papers/20498670PubMed
813,731,742Anuphylactic reactions in the skin of the guinea pig with high and low molecular weight antibodies and gamma globulins.J Exp Med1960https://conductscience.org/library/papers/13731742PubMed
98,047,141Active anaphylaxis in IgE-deficient mice.Nature1994https://conductscience.org/library/papers/8047141PubMed
1021,436,586Mouse and human neutrophils induce anaphylaxis.J Clin Invest2011https://conductscience.org/library/papers/21436586PubMed
119,875,849Crystal structure of the human high-affinity IgE receptor.Cell1998https://conductscience.org/library/papers/9875849PubMed
1222,566,901Mast cells and company.Front Immunol2012https://conductscience.org/library/papers/22566901PubMed
1322,908,332Fcγ receptors inhibit mouse and human basophil activation.J Immunol2012https://conductscience.org/library/papers/22908332PubMed
144,100,688Immunoglobulin receptors on mouse mast cells.J Immunol1971https://conductscience.org/library/papers/4100688PubMed
1539,495,000Life-threatening antibodies: The discovery of anaphylaxis.Immunol Rev2024https://conductscience.org/library/papers/39495000PubMed
164,170,889A new class of immunoglobulin in human serum.Immunology1968https://conductscience.org/library/papers/4170889PubMed
1730,902,637A Weaning Reaction to Microbiota Is Required for Resistance to Immunopathologies in the Adult.Immunity2019https://conductscience.org/library/papers/30902637PubMed
189,766,193[The discovery of anaphylaxis: 19 days after an anodyne account of toxicology, it is shown that immunity is perhaps pathogenic].C R Acad Sci III1998https://conductscience.org/library/papers/9766193PubMed
1934,343,358EAACI guidelines: Anaphylaxis (2021 update).Allergy2022https://conductscience.org/library/papers/34343358PubMed
2026,200,011Barrier Epithelial Cells and the Control of Type 2 Immunity.Immunity2015https://conductscience.org/library/papers/26200011PubMed

See all 50 references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
39,495,000Life-threatening antibodies: The discovery of anaphylaxis.Immunol Rev2024https://conductscience.org/library/papers/39495000

Source PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39495000

GET https://conductscience.org/api/papers/v1/39495000/references?page=2